A Chinese phase 3 trial of Bristol Myers Squibb’s antibody-drug conjugate has hit its dual primary survival endpoints, providing further validation of the Big Pharma's $800 million bet on the ...

Joy Emeh is a professional health writer, editor, content strategist, and career development coach with up to four years of experience in the health writing space. She is interested in all things ...

“Breast cancer was the furthest thing from my mind,” Jacob Johnson tells PEOPLE ...

Despite recent advancements in breast cancer treatments, new breast cancer cases in women are predicted to rise by a third globally from 2.3 million in 2023 to more than 3.5 million in 2050. Similarly ...

Where a woman lives significantly affects whether her breast cancer is diagnosed at an early or late stage, according to a national analysis published in the Journal of the American College of ...

The treatment landscape for breast cancer is shifting rapidly, driven by the rise of antibody-drug conjugates (ADCs), a class of treatments that are designed to deliver potent che ...

Postmenopausal obesity increases ER-positive breast cancer risk, particularly in non-HRT users, while premenopausal overweight may lower risk.

FDA Priority Review was granted for trastuzumab deruxtecan in post-neoadjuvant HER2-positive early breast cancer with residual invasive disease, with a regulatory decision anticipated in Q3 2026.

Shocked. Michelle Reiss never thought she'd hear the word cancer, let alone Hodgkin lymphoma, about herself. But that was the diagnosis the now 36-year-old faced in 2024. Questions swirled: What ...

A study that evaluated over 4000 patients with breast cancer found that, with a median follow-up of 18 years, history of ...

Katie Thurston was diagnosed with breast cancer in February 2025 at the age of 34. “I had a small lump in my breast around the 10’oclock [sic] spot,” the former Bachelorette wrote via her Instagram ...

Arm lymphedema was reported in 13% of patients in the experimental group and 12% in the control group. Survival and safety outcomes were also similar with both regimens, study researchers reported.